Charles River Laboratories International CRL
NYSE CRL
$301.88 +2.86 (+0.96%)
As of: Oct 14, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011)

Updated

Analysis

Charles River Laboratories International (CRL) Curent Deferred Tax Liability (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn -
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn -
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn -
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn -
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn -
7 Evotec SE 506.10 Mn -1.10 Bn - 8.08 Mn
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn -
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn -
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 1.07 Mn
Jun 25, 2011 1.12 Mn
Dec 25, 2010 963,000.00
API Access

Charles River Laboratories International Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=CRL&period=max&api_key=YOUR_API_KEY